Herbert Irving Comprehensive Cancer Center
Markus Mapara, MD

Dr. Mapara is Professor of Medicine at Columbia University Medical Center and the Director of the Blood and Marrow Transplantation (BMT). Dr. Mapara graduated from the University of Heidelberg Medical School/Germany, and received his post-graduate training in Internal Medicine and Hematology/Oncology at the Universities of Heidelberg and the University Medical Center Charite of the Humboldt University of Berlin in Germany. In addition, he completed a research fellowship at the Transplantation Biology Research Center of the Massachusetts General Hospital at the Harvard Medical School in Boston. As Assistant Professor of Medicine, he headed the Hematologic Intensive Care Unit and served as deputy director of the Stem Cell Transplantation unit at the University Medical Center Charité in Berlin, Germany. Before coming to Columbia, Dr. Mapara was Associate Professor of Medicine (with tenure) at the University of Pittsburgh Cancer Institute and served as the Director of the Adult Hematopoietic Stem Cell Transplantation Program.

Clinical Studies Managed By This Investigator:
Condition Study Title
Stem Cell Transplant [ CLOSED ] A study for stem cell transplant patients using study drug CSJ148
Lymphoma [ CLOSED ] Study for patients with Diffuse Large B-Cell Lymphoma (DLBCL) using stem cells
Blood Disorders [ CLOSED ] A study for patients with severe Sickle Cell Disease using study drug
Stem Cell Transplant Research Database for Cell Transplant and Other Cellular Therapies
Sickle Cell Disease [ CLOSED ] Study of CTX001 in Patients with Severe Sickle Cell Disease (SCD)
Stem Cell Transplant [ CLOSED ] Study of Itacitinib and Tocilizumab for the Treatment of Steroid Refractory Acute Graft versus Host Disease in Stem Cell Transplant
Blood Disorders [ CLOSED ] Study of CRISPR-CAS9 Modified CD34+ Human Hematopoietic Stem and Progenitor Cells (hHSPCS) in Subjects with Beta-Thalassemia
Cancer [ CLOSED ] Study of RGI-2001 (Investigational Drug) for Prevention of Acute Graft Versus-Host Disease (aGvHD) in Subjects after Stem Cell Transplant
Leukemia Study of VOR33 in Patients with Acute Myeloid Leukemia (AML)
Transplant Bone Marrow Transplant (BMT) Study in Patients with Acute Leukemia
Leukemia Bone Marrow Transplant (BMT) Study in Patients with Acute Leukemia